Workforce Serosurveillance to Track Long-term Modifications to COVID-19 Exposure Due to Factors in the Built Environment

CompletedOBSERVATIONAL

Enrollment

40,132

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

July 31, 2022

Study Completion Date

December 31, 2022

Conditions

Covid19

Interventions

BIOLOGICAL

Antibody testing

The antibody results include understanding modifications from environments at work and the community.

Trial Locations (1)

Feinstein Institutes for Medical Research, Northwell Health, Great Neck